🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators would like to conduct a prospective, multicenter, two-arm...
Status
Unknown
Location
Kantonspital Aarau
Start Date
2022-12-01
Trial ID
NCT05606588
Treatments Being Tested
This pilot study aims to evaluate the feasibility of Managing Fatigue: The ...
Status
Completed
Location
Dalhousie University
Start Date
2020-11-02
Trial ID
NCT04267107
Treatments Being Tested
My MS Toolkit is a web-based symptom self-management program for persons wi...
Status
Completed
Location
University of Michigan
Start Date
2019-02-26
Trial ID
NCT03708276
Treatments Being Tested
Fatigue is present in at least 60% of the patients with a muscle disease an...
Status
Completed
Location
Radboudumc
Start Date
2014-08
Trial ID
NCT02208687
Treatments Being Tested
The implementation of a non-pharmacological multimodal intervention program...
Status
Recruiting
Location
Hospital Clinic de Barcelona
Start Date
2025-02-06
Trial ID
NCT07161245
Treatments Being Tested
My MS Toolkit is a web-based symptom self-management program for persons wi...
Status
Completed
Location
The University of Michigan
Start Date
2020-10-19
Trial ID
NCT04552561
Treatments Being Tested
The aim of our study is to compare the effects of progressive exercise ther...
Status
Unknown
Location
Merve Betül Öztarsu
Start Date
2021-05-24
Trial ID
NCT05000398
Fatigue is a common and problematic symptom of end-stage renal disease (ESR...
Status
Completed
Location
South Calgary Health Centre
Start Date
2019-02-21
Trial ID
NCT03825770
Treatments Being Tested
Self-efficacy predicts behavioural and rehabilitation outcomes and may be a...
Status
Completed
Location
GF Strong Rehabilitation Centre
Start Date
2013-03
Trial ID
NCT01838135
Treatments Being Tested
The proposed study is a Phase II, feasibility, randomized controlled prefer...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2022-12-02
Trial ID
NCT05424068
Treatments Being Tested